Needle-use declarations at the Olympic Games Rio 2016.

Area of Science:

• Sports Medicine
• Public Health
• Doping Control

Background:

• The International Olympic Committee (IOC) implemented a 'Needle Policy' for the Rio 2016 Olympic Games.
• The policy aimed to regulate needle use in team medical settings, ensuring physician oversight and safety for support staff.
• It also served to document procedures as part of the anti-doping program.

Purpose of the Study:

• To evaluate the implementation and outcomes of the IOC Needle Policy during the Rio 2016 Olympic Games.
• To assess the types of products administered via needles and the prevalence of their use.
• To understand physician compliance and identify areas for improvement in needle-use policies for future events.

Main Methods:

• Physician-submitted 'Injection Declaration Forms' were collected and archived.
• Data on needle use, including products, physicians, athletes, and National Olympic Committees (NOCs), were categorized.
• Analysis focused on the frequency and nature of declared needle administrations.

Main Results:

• A total of 367 needle-use declarations were received from physicians representing 49 NOCs.
• Needle use was most frequent in athletics, gymnastics, football, and aquatics.
• Local anesthetics, glucocorticoids, NSAIDs, and analgesics were the most commonly declared products, with 60% of cases involving a single product.

Conclusions:

• The IOC Needle Policy aimed to minimize non-physician needle use, promote evidence-based practice, and deter doping.
• Declarations from 49 out of 209 NOCs suggest potential underreporting or varied compliance.
• Further efforts are needed to enhance policy compliance and needle-use documentation in future Olympic Games.